ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
0,00%
S&P 500
5.127,79
0,00%
US Dollar vs BRL
5,0842
0,23%
Bitcoin
63.565,35
-0,68%
Brent Oil
83,355
0,28%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) Notícias

NVAX

Novavax (NVAX)

Novavax Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVAX
DataHoraFonteTítuloCódigoCompanhia
06/05/202407:22GlobeNewswire Inc.Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingNASDAQ:NVAXNovavax Inc
15/04/202407:00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202409:00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
05/03/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
29/02/202418:02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
28/02/202410:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
28/02/202410:00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202409:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
23/02/202410:03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202408:00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
20/02/202411:25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
03/01/202411:25PR Newswire (US)Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NVAXNovavax Inc
18/12/202310:00PR Newswire (US)Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in TaiwanNASDAQ:NVAXNovavax Inc
13/12/202319:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/12/202310:31Dow Jones NewsModerna Shares, Other Covid Vaccine Makers Hit by Warning From PfizerNASDAQ:NVAXNovavax Inc
13/12/202310:00PR Newswire (Canada)Canadians Can Help Protect Loved Ones as We Head into the Holiday SeasonNASDAQ:NVAXNovavax Inc
05/12/202318:01PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Authorized in CanadaNASDAQ:NVAXNovavax Inc
28/11/202315:13IH Market NewsWall Street Radar: Amazon, Blackrock, General Motors, Eli Lilly, Novavax..NASDAQ:NVAXNovavax Inc
28/11/202308:00PR Newswire (US)Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health OrganizationNASDAQ:NVAXNovavax Inc
17/11/202309:15PR Newswire (US)Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic PrioritiesNASDAQ:NVAXNovavax Inc
10/11/202311:25PR Newswire (US)Novavax to Participate in Jefferies London Healthcare ConferenceNASDAQ:NVAXNovavax Inc
09/11/202310:00PR Newswire (US)Novavax Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
09/11/202309:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
09/11/202309:02IH Market NewsThursday’s Wall Street Highlights: Nvidia, Duolingo, Disney, Virgin Galactic, Applovin, and moreNASDAQ:NVAXNovavax Inc
08/11/202308:59IH Market NewsWednesday’s Wall Street Highlights: Spirit AeroSystems, Upstart, Toast, Upwork, Take-Two, Sleep Number, and moreNASDAQ:NVAXNovavax Inc
02/11/202318:00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NVAXNovavax Inc
02/11/202310:25PR Newswire (US)Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023NASDAQ:NVAXNovavax Inc
31/10/202317:48PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Approved in the EUNASDAQ:NVAXNovavax Inc
31/10/202314:08PR Newswire (US)Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EUNASDAQ:NVAXNovavax Inc
18/10/202309:05PR Newswire (US)Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United KingdomNASDAQ:NVAXNovavax Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVAX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRKM5
BRASKEM PNA
BOV
TELB4
TELEBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
AZEV4
AZEVEDO PN
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados